These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39235155)
1. Organic Chimeras based on Selenosugars, Steroids, and Fullerenes as Potential Inhibitors of the β-amyloid Peptide Aggregation. Lemos R; Pérez-Badell Y; De Nisco M; Carpentieri A; Suárez M; Pedatella S Chempluschem; 2024 Sep; ():e202400404. PubMed ID: 39235155 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of [60]Fullerene Hybrids Endowed with Steroids and Monosaccharides: Theoretical Underpinning as Promising anti-SARS-CoV-2 Agents. Lemos R; Makowski K; Almagro L; Tolón B; Rodríguez H; Herranz MÁ; Molero D; Martín N; Suárez M European J Org Chem; 2023 Jan; ():e202201301. PubMed ID: 36721524 [TBL] [Abstract][Full Text] [Related]
3. The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment. Xie L; Luo Y; Lin D; Xi W; Yang X; Wei G Nanoscale; 2014 Aug; 6(16):9752-62. PubMed ID: 25004796 [TBL] [Abstract][Full Text] [Related]
4. Click synthesis of dendronized malonates for the preparation of amphiphilic dendro[60]fullerenes. Cruz-Hernández C; López-Camacho PY; Basurto-Islas G; Rojas A; Guadarrama P; Martínez-Herrera M Org Biomol Chem; 2024 Apr; 22(16):3328-3339. PubMed ID: 38584463 [TBL] [Abstract][Full Text] [Related]
5. Dumbbell-type fullerene-steroid hybrids: a join experimental and theoretical investigation for conformational, configurational, and circular dichroism assignments. Ruíz A; Morera-Boado C; Almagro L; Coro J; Maroto EE; Herranz MÁ; Filippone S; Molero D; Martínez-Álvarez R; Garcia de la Vega JM; Suárez M; Martín N J Org Chem; 2014 Apr; 79(8):3473-86. PubMed ID: 24665860 [TBL] [Abstract][Full Text] [Related]
6. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Sun Y; Qian Z; Wei G Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578 [TBL] [Abstract][Full Text] [Related]
7. Multiadducts of C60 Modulate Amyloid-β Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies. Martínez-Herrera M; Figueroa-Gerstenmaier S; López-Camacho PY; Millan-Pacheco C; Balderas-Altamirano MA; Mendoza-Franco G; García-Sierra F; Zavala-Ocampo LM; Basurto-Islas G J Alzheimers Dis; 2022; 87(2):741-759. PubMed ID: 35367963 [TBL] [Abstract][Full Text] [Related]
8. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies. Azam F; Alabdullah NH; Ehmedat HM; Abulifa AR; Taban I; Upadhyayula S J Biomol Struct Dyn; 2018 Jun; 36(8):2099-2117. PubMed ID: 28571516 [TBL] [Abstract][Full Text] [Related]
10. Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation. Pandya V; Baweja L; Dhawan A Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):71-73. PubMed ID: 29593399 [TBL] [Abstract][Full Text] [Related]
11. Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-β Peptides Revealed by Molecular Dynamics Simulations. Liu Z; Zou Y; Zhang Q; Chen P; Liu Y; Qian Z Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027286 [TBL] [Abstract][Full Text] [Related]
12. Fullerenol C60(OH)16 prevents amyloid fibrillization of Aβ40-in vitro and in silico approach. Bednarikova Z; Huy PD; Mocanu MM; Fedunova D; Li MS; Gazova Z Phys Chem Chem Phys; 2016 Jul; 18(28):18855-67. PubMed ID: 27350395 [TBL] [Abstract][Full Text] [Related]
13. Design of multi-target compounds as AChE, BACE1, and amyloid-β(1-42) oligomerization inhibitors: in silico and in vitro studies. Hernández-Rodríguez M; Correa-Basurto J; Martínez-Ramos F; Padilla-Martínez II; Benítez-Cardoza CG; Mera-Jiménez E; Rosales-Hernández MC J Alzheimers Dis; 2014; 41(4):1073-85. PubMed ID: 24762947 [TBL] [Abstract][Full Text] [Related]
14. Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein. Boopathi S; Kolandaivel P J Mol Model; 2014 Mar; 20(3):2109. PubMed ID: 24567151 [TBL] [Abstract][Full Text] [Related]
15. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718 [TBL] [Abstract][Full Text] [Related]
16. Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease. Orjuela A; Lakey-Beitia J; Mojica-Flores R; Hegde ML; Lans I; Alí-Torres J; Rao KS J Alzheimers Dis; 2021; 82(s1):S321-S333. PubMed ID: 33337368 [TBL] [Abstract][Full Text] [Related]
17. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors. Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379 [TBL] [Abstract][Full Text] [Related]
18. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]
19. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide. Drew SC; Barnham KJ Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease. Das B; Tk Baidya A; Chakrabarti S; Chouhan D; Thakur B; Darreh-Shori T; Chen G; Tiwari V; Kumar R Bioorg Chem; 2024 Jun; 147():107373. PubMed ID: 38653149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]